Pamela Scott
Family · Visalia, CANPI 1356620181
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $116,761 of the $165,058 with a category attached, or 70.7%. 25 manufacturers reported payments, led by Johnson & Johnson at 29.9% of the total. 2025 is the largest year on record at $58,367, 3.7 times the $15,908 reported in 2021. Among family clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 589 payments — averaging $280.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$49K
- Mallinckrodt Hospital Products Inc.$41K
- Amgen$29K
- Janssen Scientific Affairs, LLC$26K
- AstraZeneca$13K
- AbbVie$2K
- plus $4K from 19 others
What the payments were for
- Consulting fees$5,7443%
- Speaking & faculty fees$116,76171%
- Travel & lodging$27,48017%
- Food & beverage$15,0089%
- Education$650%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 157 | $49,278 |
| Mallinckrodt Hospital Products Inc. | 53 | $40,846 |
| Amgen(2 entities) | 105 | $29,178 |
| Janssen Scientific Affairs, LLC | 34 | $25,932 |
| AstraZeneca | 56 | $13,137 |
| AbbVie | 82 | $2,253 |
| GSK | 25 | $941 |
| Aurinia Pharma U.S., Inc. | 8 | $701 |
| Novartis | 18 | $656 |
| Sanofi | 3 | $547 |
| UCB, Inc. | 10 | $527 |
| Boehringer Ingelheim | 9 | $286 |
| Pfizer | 6 | $161 |
| Braeburn Inc. | 1 | $123 |
| E.r. Squibb & Sons, L.L.C. | 5 | $89 |
| Ipsen Biopharmaceuticals, Inc | 3 | $70 |
| ANI Pharmaceuticals, Inc. | 3 | $66 |
| Sanofi-aventis U.S. LLC | 1 | $60 |
| Lilly USA, LLC | 3 | $51 |
| Radius Health, Inc. | 2 | $38 |
| Fresenius Kabi USA, LLC | 1 | $33 |
| Organon | 1 | $26 |
| Genentech USA, Inc. | 1 | $23 |
| Kyowa Kirin, Inc. | 1 | $21 |
| Alvogen Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$165,058 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RinvoqUpadacitinib | 62 | $444,967 |
| Humira(Cf) PenAdalimumab | 49 | $346,127 |
| Enbrel SureclickEtanercept | 31 | $229,849 |
| OtezlaApremilast | 33 | $159,375 |
| Cosentyx Sensoready PenSecukinumab | 12 | $102,602 |
| Orencia ClickjectAbatacept | 11 | $90,067 |
| RasuvoMethotrexate/Pf | 22 | $18,121 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 442 | $12,179 |
| Hydroxychloroquine Sulfate | 162 | $6,751 |
| Celecoxib | 66 | $5,348 |
| Mycophenolate Mofetil | 30 | $4,673 |
| Gabapentin | 141 | $4,390 |
| Diclofenac Sodium | 116 | $4,085 |
| Azathioprine | 102 | $3,942 |
| MethotrexateMethotrexate Sodium | 115 | $2,767 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq | $2,253 | $444,96762 claims |
| AmgenOtezla | $29,178 | $159,37533 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,634 family providers in California.
Other family in Visalia
- Maribel TorresVisalia$57K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.